Editorial p1265 Lenacapavir—time to change the game for everyone The Lancet Infectious Diseases +++ +...

Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9–14 years compared with three doses of quadrivalent HPV vaccine in women aged 18–25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00284-1/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsenc=p2ANqtz--L_JGaXKO7ug0oIeUX3ULppCoCTcUTGP1Tr_FT-L2j7c1BtesnbmSWzZF9awNInGpB2H9dcMtife1hXQb20AJGrltheg&_hsmi=392624890&utm_content=392596276&utm_source=hs_email Estimating measles susceptibility and transmission patterns in Italy: an epidemiological assessment https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00293-2/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz--n4sI29JZqk_zX2t2pU_23ggeyb_PDKrClL0-NlbBaNORHjsJF9hYInckV6I0r6-_N6lYjp4eyfTofAAbpjlR5g0Av8w&_hsmi=392624890&utm_content=392596276&utm_source=hs_email The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00305-6/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-__pg6tk7RuxK_aQ-hdrK6QDwq-QGlqXlDT2Bst8Mby_wGy5lLrvj74SsCX9Cj_OxMoh80-dJB9JsWutLwgIrk7K9wdcQ&_hsmi=392624890&utm_content=392596276&utm_source=hs_email Editorial p1265 Lenacapavir—time to change the game for everyone The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/issue/vol25no12/PIIS1473-3099(25)X0012-8